Aug 24, 2026 07:35AM
May 15, 2026 07:31AM
May 14, 2026 07:31AM
May 6, 2026 07:31AM
Mar 31, 2026 04:06PM
Jan 13, 2026 07:36AM
Dec 23, 2025 08:28AM BriaCell Therapeutics announces public offering of up to $25 million
Oct 21, 2025 07:31AM
Oct 14, 2025 06:42AM
Aug 27, 2025 06:36AM
Aug 26, 2025 07:38AM
Aug 25, 2025 07:31AM
Aug 21, 2025 12:08PM
Aug 13, 2025 07:30AM BriaCell joins MSK cancer therapeutics accelerator program
Jul 30, 2025 07:31AM
Jul 11, 2025 06:39AM
Jul 8, 2025 04:11PM
Jul 8, 2025 07:32AM
Jul 2, 2025 07:31AM
Jun 24, 2025 07:38AM
May 27, 2025 07:31AM BriaCell Therapeutics' (BCTX) Bria-OTS Phase 1/2 Study Clears Safety Evaluation
May 23, 2025 07:42AM
Apr 24, 2025 07:32AM
Apr 23, 2025 06:39AM
Apr 22, 2025 07:31AM
Apr 16, 2025 07:31AM
Mar 20, 2025 08:02AM
Feb 13, 2025 04:55PM BriaCell (BCTX) regains Nasdaq compliance with bid price
Feb 4, 2025 06:39AM
Feb 3, 2025 04:45PM
Feb 3, 2025 07:31AM
Dec 11, 2024 04:05PM
Dec 2, 2024 12:24PM
Dec 2, 2024 07:50AM
Oct 15, 2024 07:51AM BriaCell Therapeutics (BCTX) Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Study
Oct 3, 2024 07:03AM
Oct 1, 2024 02:05PM
Oct 1, 2024 07:55AM
Sep 19, 2024 06:41AM
Sep 12, 2024 07:51AM
Sep 11, 2024 12:10PM
Sep 10, 2024 07:51AM BriaCell Therapeutics (BCTX) Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer
Jul 18, 2024 07:57AM

445,676 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All